21 - Endocarditis Flashcards

(46 cards)

1
Q

Catheter-Related Bacteremia/Sepsis
Vs
Localized Catheter site infection

A

Catheter-related bacteremia/sepsis
positive catheter culture

•ositive peripheral blood culture

same microorganism isolated in both 1 & 2

Localized catheter site infection
Clinically or microbiologically proved infection at the catheter exit site
(e.g., cellulitis, purulence, tunnelitis, pocket infections)
No systemic signs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Trans-THORACIC echocardiogram

A

less invasive

QUICKER

better at
quantifying hemodynamic dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Treatment for:

STREP
Veridans / Gallolyticus / Abiotrophia / Granulicatella

NVE
(native valve endocarditis)

  • *PCN - Intermediate Resistance**
  • *MIC > 0.12 , <0.5**
A
  • *Penicillin G Sodium**
  • *24 million** units per 24 hours
  • *4 WEEKS**

++PLUS++

  • *Gentamicin**
  • *3mg/kg** per 24 hours
  • *2 WEEKS**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Indications for
LONG-TERM CATHETERS

PICC

Port-a-cath

Groshong = CLosed end

Hickman = open end

A
  • Lack of short term peripheral venous access (e.g, IV drug users)
  • Infusion of hyperosmolar solutions (e.g., TPNs)
  • Infusion of vessicant/ irritant drugs (e.g., certain chemotherapy)
  • Long-term IV therapy (e.g., treatment of endocarditis)
  • Infusion of intermittent drug therapy (e.g., chemotherapy)
  • Use of continuous ambulatory drug pumps (e.g., TPN)
  • Patient, physician or nursing preference
  • Geographic location (e.g., lives out in the country)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Prevention** **for Infective Endocarditis

Unable to take ORAL

Prosthetic Valve or Material
previous IE
CHD

Dental procedures

A
  • *Ampicillin**
  • *2gm IM or IV**

1 hour before procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bacterial ETIOLOGY
of
CR-BSI

A

Coagulase Negative STAPHylococcus

All Gram Negative Bacteria

Enterococci = STAPH.Areus

Candida

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CR-BSI TREATMENT:

STAPHYLOCOCCUS AUREUS

RESISTANCE

A

Methicillin Resistant Strains

  • *Vancomycin**
  • *15mg/kg q12**

OR

  • *Daptomycin**
  • *6-8mg/kg**

2-6 WEEKS
REMOVE LINE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Treatment for:

GRAM NEGATIVE BACILLI
Infective Endocarditis

A
  • *B-Lactam_ + _AminoGlycoside**
  • *6 WEEKS**

REQUIRES VALVE REPLACEMENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatment for:

GRAM NEGATIVE BACILLI
Infective Endocarditis

A
  • *B-Lactam_ + _AminoGlycoside**
  • *6 WEEKS**

REQUIRES VALVE REPLACEMENT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Treatment for:

STAPH Aureus
Coagulase-Negative Staphylococci

NVE
(Native Valve Endocarditis)

PCN ALLERGY

A
  • *Vancomycin**
  • *30mg/kg** QD
  • *6 WEEKS**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment for:

Enterococcuus
Coagulase-Negative Staphylococci

PVE** or **NVE
(Prosthetic OR native)

RESISTANT STRAINS
to PCN / Vancomycin / Gentamicin

A
  • *LINEZOLID**
  • *600mg** IV or ORAL q12 hr
  • *>** 6 Weeks

OR

  • *DAPTOMYCIN**
  • *10-12 mg/kg per dose**
  • *>** 6 Weeks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

trans-ESOPHAGEAL echocardiogram

A

more SENSITIVE

cost-effective

Recommended in patients with:
PROSTHETIC Valves

Previous Cardiothoracic Surgery

COPD

MORBID OBESITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Prevention** **for Infective Endocarditis

ORAL

Prosthetic Valve or Material
previous IE
CHD

Dental procedures

A
  • *AMOXICILLIN**
  • *2gm**

1 hour before procedure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment for:

STAPH Aureus
Coagulase-Negative Staphylococci

PVE
(Prosthetic)

RESISTANT STRAINS

A
  • *PVE STAPH = 3 DRUGS** + >6 week treatment
  • Resistant –> vanco instead of oxacillin*

VANCOMYCIN
30mg/kg per 24hr in 2dd
> 6 WEEKS
++++
Rifampin
900mg per 24 hours
> 6 WEEKS
+++
Gentamicin
3mg/kg per 24 hours
2 WEEKS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prevention** **for Infective Endocarditis

PCN / Ampicillin Allergy
UNABLE TO TAKE ORAL

Prosthetic Valve or Material

previous IE
CHD

Dental procedures

A
  • *CLINDAMYCIN**
  • *600mg IM or IV**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Risk Factors
Infective Endocarditis

A

Heart Disease
Rheumatic / Congenital / Acquired
Patent Ductus - Mitral Valve prolapse

Prosthetic Valves

Previous Bacterial endocarditis

ways bacteria could be introduced:
Indwelling Catheters
IV DRUG USE
DENTAL / SURGICAL procedures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Treatment for:

STREP
Veridans / Gallolyticus / Abiotrophia / Granulicatella

PVE
(Proshetic Valve Endocarditis)

  • *PCN SENSITIVE**
  • *MIC < 0.12**
A
  • *Penicillin G sodium**
  • *24 million** units for 24 hours
  • *6 WEEKS**

with or without

  • *Gentamicin**
  • *3mg/kg** per 24 hours in 1 dose
  • *2 WEEKS**
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

When should the
Catheter be PULLED

for
CR-BSI

A

Short Term Use

Supperative Thrombophlebitis

Severe Sepsis / Endocarditis / Osteomylitis

+POS+ Blood cultures after 72 hours
& receiving ABx therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Treatment for:

FUNGI
Infective Endocarditis

A
  • *Amphotericin B** +/- Flucytosine
  • treatment duration is UNKNOWN*

REQUIRES VALVE REPLACEMENT

20
Q

CR-BSI TREATMENT:

Coagulase-Nagative STAPHylococcus

A
  • *VANCOMYCIN**
  • *15mg/kg q12h**

AB LOCK

10 - 14 day treatment

20% recurrence if catheter NOT REMOVED

21
Q

DIAGNOSIS of CR-BSI

A

CATHETER TIP CULTURE
> 15 CFU
has to be the TIP
+
2 Peripheral blood Cultures

22
Q

Treatment for:

STAPH Aureus
Coagulase-Negative Staphylococci

PVE
(Prosthetic)

No resistance / Susceptible Strains

A

PVE STAPH = 3 DRUGS + >6 week treatment

Nafcillin** or **Oxacillin
12g per 24h
> 6 WEEKS
++++
Rifampin
900mg per 24 hours
> 6 WEEKS
+++
Gentamicin
3mg/kg per 24 hours
2 WEEKS

23
Q

Treatment for:

STAPH Aureus
Coagulase-Negative Staphylococci

NVE
(Native Valve Endocarditis)

No Resistance = Susceptible Strains

A
  • *Oxacillin_ or _Nafcillin**
  • *12g / 24h** in 4-6 dd
  • *6 WEEKS**
24
Q

Prevention of endoluminal contamination

A

Aseptic hub handling

↓#of connections

Separate the hub from the skin

↓changes of infusion sets

↓ of catheter lumens/ ports

↓catheter manipulations

25
**Which patients should recieve _PROPHYLAXIS_** for **Infective Endocarditis?**
**_Prosthetic Valve**_ OR _**Material_** **_Previous IE_** infective endocarditis **_CONGENITAL HEART DISEASE_** **palliative shunts / conduits** **repaired** congenital heart defects cardiac **TRANSPLANTATIOn recipients**
26
Patient **_RISKS_** From **long-term catheter placement**
Local site infection **tunnel** or **pocket** Catheter-related bloodstream infection = **_CR BSI_** * **Septic thrombophlebitis** * **Endocarditis** •Metastatic infections (e.g.**, lung abscess, brain abscess, osteomyelitis, endophthalmitis)**
27
**CR-BSI TREATMENT:** **_ENTEROCOCCI_** & **VRE (Vanco Resistant Enterococci)**
*same as Coagulase Negative STAPH* **_VANCOMYCIN_** **15mg/kg q12h AB LOCK 10 - 14 day treatment** **_for isolated VRE - ​PULL LINE_** **_Daptomycin_** - **6mg/kg/day** OR **_Linezolid_** - **600mg q12h**
28
**CR-BSI TREATMENT:** **_GRAM NEGATIVE BACILLI_**
**Piperacillin/Tazobactam** **Ceftazidime** or **Cefipime** **Imipenem** or **Meropenem** +/- **aminoglycoside** **_7-14 days_** ***_REMOVE THE CATHETER_***
29
**Treatment for:** **_STAPH Aureus_** Coagulase-Negative Staphylococci **_NVE_** (Native Valve Endocarditis) **_RESISTANT STRAINS_**
* *_Vancomycin_** * *30mg/kg** per 24 hours in **2dd** * *6 WEEKS** same as PCN allergic
30
``` **Pathogenesis of INFECTIVE ENDOCARDITIS (IE)** ```
Insult to the **Valvular** or **Endocardial Endothelium** allowing for **deposition** of **_PLATELET-FIBRIN_** aggregates **_NBTE_** **(Non-Bacterial Thrombotic Endocarditis)** **/ Vegetations** acts as the: ideal spot for **BACTERIAL ADHERENCE**
31
**Diagnosis of Infective Endocarditis**
Clinical Presentations: **embolic phenomenom / OSLER nodes / janeway lesions splenomegaly** * *_BLOOD CULTURES_** * *Continuous BACTEREMIA** * *3 Sets** @different **SITES &** **TIMES = 1-2sets/day until negative** **_ECHOCARDIOGRAM_** Trans-thorasic vs Trans-esophageal
32
**Treatment for:** **_Enterococcuus_** Coagulase-Negative Staphylococci **_PVE**_ or _**NVE_** (Prosthetic OR native) ***_NO RESISTANCE_*** to **PCN / Vancomycin / Gentamicin**
* *_AMPICILLIN_** * *2g** every **4hrs** * *4-6 WEEKS** for PCN allergy: **Vancomycin + Gentamycin**
33
**Etiologic Agents in** ​Infective Endocarditis
* *_STAPHYLOCOCCI_** * *Positive \> negative** **_Streptococci_** Veridans \> other **Enterococci** **Gram-Negative** **Fungi** **Etc**
34
**Treatment for:** **_STREP_** Veridans / Gallolyticus / Abiotrophia / Granulicatella **_NVE_** (native valve endocarditis) **_PCN ALLERGY_**
* *_Vancomycin_** * *30mg/kg** per **24 hours** in 2divdoses * *4 WEEKS** for **PVE --\> 6 Week treatment**
35
**_Septic thrombophlebitis_**
Evidence of **_venous THROMBUS_** of the **vein** with indwelling catheter & positve blood cultures with **clinical manifestations of sepsis**
36
**CR-BSI TREATMENT:** **_CANDIDA_**
* *_14 DAYS_** * *_REMOVE THE CATHETER_** **CASPOFUNGIN** **AMPHOTERICIN B** **FLUCONAZOLE**
37
**_SITUATIONS_** **where patients should receive _PROPHYLAXIS_** **Infective Endocarditis**
all **DENTAL procedures** that involve **manipulation of : _gingival tissue**_or_**periapical region of teeth**_or_**perforation of oral mucosa_** **_*no longer recommended for NON-DENTAL PROCEDURES*_** in the absence of active enfection
38
**_Prevention**_ _**for Infective Endocarditis_** **ORAL PCN / Ampicilin ALLERGY** Prosthetic Valve or Material previous IE CHD Dental procedures
* *_Clindamycin_** * *600mg** **OR** * *_Azithromycin_** or **_Clarithromycin_** * *500mg** 1 hour before procedure
39
**_Infusate-related bacteremia_**
presense of the * *same pathogen in BLOOD & INFUSATE** * **_without ID of alternative sites of infection_***
40
**Mouth Bacteria**
**_H-A-C-E-K_** **Haemophilus** **Aggregatibacter** **Cardiobacterium** **Eikenella** **Kingella**
41
**Treatment for:** **_HACEK_** Haemophilus / Aggregatibacter / Cardiobacterium / Eikenella-Kingella Responsible for 5-10% of community aquired NVE
* *_CEFTRIAXONE_** * *2g** per **24hours** IV or IM **1 dose** ## Footnote **4 WEEKS**
42
**Treatment for:** **_STREP_** Veridans / Gallolyticus / Abiotrophia / Granulicatella **_NVE_** (native valve endocarditis) * *_PCN SENSITIVE_** * *MIC \< 0.12**
* *_Penicillin G sodium_** * *12-18** million units / **24** hours * *4 WEEKS** OR **_Penicillin**_ + _**Gentamicin_** same + **3mg/kg** / 24 hours **2 WEEKS**
43
**_RISK FACTORS_** for **CR-BSI** Catheter related Bloodstream Infections
**_Cutaneous**_ vs _**Subcutaneous Ports_** ↑**# of LUMENS** * *LENGTH of TIME in place** * *_\>3 days_** *Poor sterile insertion technique* **Insertion Site** **TPN Used**
44
**Treatment for:** **_STREP_** Veridans / Gallolyticus / Abiotrophia / Granulicatella **_PVE_** (Proshetic Valve Endocarditis) * *_PCN Resistant_** * *MIC \> 0.12**
*Same as PCN resistant, but PLUS gentamicin is 6 WEEKS (not 2)* * *_Penicillin G sodium_** * *24 million** units for 24 hours * *6 WEEKS** ++PLUS++ * *_Gentamicin_** * *3mg/kg** per 24 hours in 1 Dose * *6 WEEKS**
45
**Treatment for:** **_HACEK_** Haemophilus / Aggregatibacter / Cardiobacterium / Eikenella-Kingella Responsible for 5-10% of community aquired NVE
* *_CEFTRIAXONE_** * *2g** per **24hours** IV or IM **1 dose** ## Footnote **4 WEEKS**
46
**CR-BSI TREATMENT:** **_STAPHYLOCOCCUS AUREUS_** ***no resistance***
* *_Nafcillin_** or **_Oxacillin_** * *1-2 gm IVPB q4-6hr** ## Footnote **2-6 WEEKS** **_REMOVE LINE_**